mojeNovosti.com
Gorsky, a former vice chairman of the diversified healthcare company, became chief executive on April 26, replacing Weldon, who had served as CEO for a decade. But Weldon had retained his role as chairman, as the company continued attempts to fix manufacturing problems that have sparked recalls of Tylenol and many other over-the-counter consumer brands during the past three years.
J&J said in a release that Weldon, who has been with the company for 41 years, will retire from Johnson & Johnson in the first quarter of 2013.
(Reporting By Ransdell Pierson; Editing by Gerald E. McCormick)
Copyright 2013 mojeNovosti.com
web developer: BTGcms
